Techniques in Regional Anesthesia & Pain Management
Volume 14, Issue 2 , Pages 48-58 , April 2010

Peripheral N-methyl-D-aspartate receptors as possible targets for chronic pain treatment

  • Esperanza Recio-Pinto, PhD

      Affiliations

    • Anesthesiology and Pharmacology Departments, NYU Langone Medical Center, New York, New York
    • Corresponding Author InformationAddress reprint requests and correspondence: Esperanza Recio-Pinto, PhD, Anesthesiology and Pharmacology Departments, NYU Langone Medical Center, New York, NY 10016
    • ,
  • Cecilia Castillo, PhD

      Affiliations

    • The Centro de Biociencias y Medicina Molecular, Instituto de Estudios Avanzados IDEA, Caracas, Venezuela

References 

  1. Macrae WA. Chronic pain after surgery. Br J Anaesth. 2001;87:88–98
  2. Apfelbaum JL, Chen C, Mehta SS, et al. Postoperative pain experience: Results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003;97:534–540table of contents
  3. Petrenko AB, Yamakura T, Baba H, et al. The role of N-methyl-D-aspartate (NMDA) receptors in pain: A review. Anesth Analg. 2003;97:1108–1116
  4. Zhuo M. Plasticity of NMDA receptor NR2B subunit in memory and chronic pain. Mol Brain. 2009;2:4
  5. Wu LJ, Zhuo M. Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain. Neurotherapeutics. 2009;6:693–702
  6. Chizh BA, Headley PM. NMDA antagonists and neuropathic pain—Multiple drug targets and multiple uses. Curr Pharm Des. 2005;11:2977–2994
  7. Ikeda K. New seasonings. Chem Sens. 2002;27:847–849
  8. Lindemann B, Ogiwara Y, Ninomiya Y. The discovery of umami. Chem Sens. 2002;27:843–844
  9. Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci. 1994;17:31–108
  10. Kleckner NW, Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science. 1988;241:835–837
  11. Dingledine R, Borges K, Bowie D, et al. The glutamate receptor ion channels. Pharmacol Rev. 1999;51:7–61
  12. Kemp JA, McKernan RM. NMDA receptor pathways as drug targets. Nat Neurosci. 2002;5(suppl):1039–1042
  13. Mori H, Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology. 1995;34:1219–1237
  14. Furukawa H, Singh SK, Mancusso R, et al. Subunit arrangement and function in NMDA receptors. Nature. 2005;438:185–192
  15. Cull-Candy SG, Leszkiewicz DN. Role of distinct NMDA receptor subtypes at central synapses. Sci STKE. 2004;255:re16
  16. Monyer H, Sprengel R, Schoepfer R, et al. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science. 1992;256:1217–1221
  17. Ishii T, Moriyoshi K, Sugihara H, et al. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem. 1993;268:2836–2843
  18. Paoletti P, Neyton J. NMDA receptor subunits: Function and pharmacology. Curr Opin Pharmacol. 2007;7:39–47
  19. Nakanishi N, Tu S, Shin Y, et al. Neuroprotection by the NR3A subunit of the NMDA receptor. J Neurosci. 2009;29:5260–5265
  20. Cavara NA, Orth A, Hollmann M. Effects of NR1 splicing on NR1/NR3B-type excitatory glycine receptors. BMC Neurosci. 2009;10:32
  21. Chatterton JE, Awobuluyi M, Premkumar LS, et al. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature. 2002;415:793–798
  22. Chen BS, Roche KW. Regulation of NMDA receptors by phosphorylation. Neuropharmacology. 2007;53:362–368
  23. Logan SM, Rivera FE, Leonard JP. Protein kinase C modulation of recombinant NMDA receptor currents: Roles for the C-terminal C1 exon and calcium ions. J Neurosci. 1999;19:974–986
  24. Liao GY, Wagner DA, Hsu MH, et al. Evidence for direct protein kinase C mediated modulation of N-methyl-D-aspartate receptor current. Mol Pharmacol. 2001;59:960–964
  25. Omkumar RV, Kiely MJ, Rosenstein AJ, et al. Identification of a phosphorylation site for calcium/calmodulindependent protein kinase II in the NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem. 1996;271:31670–31678
  26. Wagner DA, Leonard JP. Effect of protein kinase C activation on the Mg(two+)-sensitivity of cloned NMDA receptors. Neuropharmacology. 1996;35:29–36
  27. Xiong ZG, Raouf R, Lu WY, et al. Regulation of N-methyl-D-aspartate receptor function by constitutively active protein kinase C. Mol Pharmacol. 1998;54:1055–1063
  28. Zheng X, Zhang L, Wang AP, et al. Protein kinase C potentiation of N-methyl-D-aspartate receptor activity is not mediated by phosphorylation of N-methyl-D-aspartate receptor subunits. Proc Natl Acad Sci USA. 1999;96:15262–15267
  29. Moriguchi S, Shioda N, Han F, et al. Galantamine enhancement of long-term potentiation is mediated by calcium/calmodulin-dependent protein kinase II and protein kinase C activation. Hippocampus. 2009;19:844–854
  30. Guo W, Wei F, Zou S, et al. Group I metabotropic glutamate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrosine phosphorylation associated with inflammatory hyperalgesia. J Neurosci. 2004;24:9161–9173
  31. Craven SE, Bredt DS. PDZ proteins organize synaptic signaling pathways. Cell. 1998;93:495–498
  32. Yamada Y, Chochi Y, Ko JA, et al. Activation of channel activity of the NMDA receptor-PSD-ninety-five complex by guanylate kinase-associated protein (GKAP). FEBS Lett. 1999;458:295–298
  33. Liao GY, Kreitzer MA, Sweetman BJ, et al. The postsynaptic density protein PSD-ninety-five differentially regulates insulin- and Src-mediated current modulation of mouse NMDA receptors expressed in Xenopus oocytes. J Neurochem. 2000;75:282–287
  34. Lu WY, Xiong ZG, Lei S, et al. G protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat Neurosci. 1999;2:331–338
  35. Kelso SR, Nelson TE, Leonard JP. Protein kinase C-mediated enhancement of NMDA currents by metabotropic glutamate receptors in Xenopus oocytes. J Physiol. 1992;449:705–718
  36. Mori H, Yamakura T, Masaki H, et al. Involvement of the carboxyl-terminal region in modulation by TPA of the NMDA receptor channel. Neuroreport. 1993;4:519–522
  37. Clapp P, Gibson ES, Dell'Acqua ML, et al. Phosphorylation regulates removal of synaptic N-methyl-d-aspartate receptors after withdrawal from chronic ethanol exposure. J Pharmacol Exp Ther. 2010;332:720–729
  38. Guo W, Zou S, Guan Y, et al. Tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord during the development and maintenance of inflammatory hyperalgesia. J Neurosci. 2002;22:6208–6217
  39. Tao F, Tao YX, Gonzalez JA, et al. Knockdown of PSD-ninety-five/SAP90 delays the development of neuropathic pain in rats. Neuroreport. 2001;12:3251–3255
  40. Beique JC, Lin DT, Kang MG, et al. Synapse-specific regulation of AMPA receptor function by PSD-95. Proc Natl Acad Sci USA. 2006;103(51):535–540
  41. Feria M, Abad F, Sanchez A, et al. Magnesium sulphate injected subcutaneously suppresses autotomy in peripherally deafferented rats. Pain. 1993;53:287–293
  42. Begon S, Pickering G, Eschalier A, et al. Magnesium and MK-801 have a similar effect in two experimental models of neuropathic pain. Brain Res. 2000;887:436–439
  43. Ishizaki K, Sasaki M, Karasawa S, et al. The effect of intrathecal magnesium sulphate on nociception in rat acute pain models. J Anesth. 1999;54:241–246
  44. Felsby S, Nielsen J, Arendt-Nielsen L, et al. NMDA receptor blockade in chronic neuropathic pain: A comparison of ketamine and magnesium chloride. Pain. 1996;64:283–291
  45. Crosby V, Wilcock A, Corcoran R. The safety and efficacy of a single dose (500 mg or 1 g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer. J Pain Symptom Manage. 2000;19:35–39
  46. Davies SN, Lodge D. Evidence for involvement of N-methylaspartate receptors in “wind-up” of class two neurones in the dorsal horn of the rat. Brain Res. 1987;424:402–406
  47. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology. 1987;26:1235–1238
  48. Davar G, Hama A, Deykin A, et al. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy. Brain Res. 1991;553:327–330
  49. Mao J, Price DD, Hayes RL, et al. Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy. Brain Res. 1993;605:164–168
  50. Mao J, Price DD, Hayes RL, et al. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. Brain Res. 1992;598:271–278
  51. Mao J, Price DD, Mayer DJ, et al. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res. 1992;576:254–262
  52. Qian J, Brown SD, Carlton SM. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy. Brain Res. 1996;715:51–62
  53. Ren K, Dubner R. NMDA receptor antagonists attenuate mechanical hyperalgesia in rats with unilateral inflammation of the hind paw. Neurosci Lett. 1993;163:22–26
  54. Ren K, Hylden JL, Williams GM, et al. The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain. 1992;50:331–344
  55. Fisher K, Coderre TJ, Hagen NA. Targeting the N-methyl-D-aspartate receptor for chronic pain management (Preclinical animal studies, recent clinical experience and future research directions). J Pain Symptom Manage. 2000;20:358–373
  56. Chaplan SR, Malmberg AB, Yaksh TL. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther. 1997;280:829–838
  57. Suzuki M. Role of N-methyl-D-aspartate receptor antagonists in postoperative pain management. Curr Opin Anaesthesiol. 2009;22:618–622
  58. Marvizon JC, McRoberts JA, Ennes HS, et al. Two N-methyl-D-aspartate receptors in rat dorsal root ganglia with different subunit composition and localization. J Comp Neurol. 2002;446:325–341
  59. Ma QP, Hargreaves RJ. Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats. Neuroscience. 2000;101:699–707
  60. Momiyama A. Distinct synaptic and extrasynaptic NMDA receptors identified in dorsal horn neurones of the adult rat spinal cord. J Physiol. 2000;523:621–628
  61. Tan PH, Yang LC, Shih HC, et al. Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Ther. 2005;12:59–66
  62. Chizh BA, Headley PM, Tzschentke TM. NMDA receptor antagonists as analgesics: Focus on the NR2B subtype. Trends Pharmacol Sci. 2001;22:636–642
  63. Malmberg AB, Gilbert H, McCabe RT, et al. Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and T. Pain. 2003;101:109–116
  64. Mony L, Kew JN, Gunthorpe MJ, et al. Allosteric modulators of NR2B-containing NMDA receptors: Molecular mechanisms and therapeutic potential. Br J Pharmacol. 2009;157:1301–1317
  65. Boyce S, Wyatt A, Webb JK, et al. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: Correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology. 1999;38:611–623
  66. Farrant M, Feldmeyer D, Takahashi T, Cull-Candy SG. NMDA-receptor channel diversity in the developing cerebellum. Nature. 1994;368:335–339
  67. Watanabe M, Inoue Y, Sakimura K, et al. Distinct distributions of five N-methyl-D-aspartate receptor channel subunit mRNAs in the forebrain. J Comp Neurol. 1993;338:377–390
  68. Gallagher MJ, Huang H, Pritchett DB, et al. Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem. 1996;271:9603–9611
  69. Perin-Dureau F, Rachline J, Neyton J, et al. Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors. J Neurosci. 2002;22:5955–5965
  70. Malherbe P, Mutel V, Broger C, et al. Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-six thousand nine hundred and eighty-one binding pocket. J Pharmacol Exp Ther. 2003;307:897–905
  71. Chazot PL. The NMDA receptor NR2B subunit: A valid therapeutic target for multiple CNS pathologies. Curr Med Chem. 2004;11:389–396
  72. Gogas KR. Glutamate-based therapeutic approaches: NR2B receptor antagonists. Curr Opin Pharmacol. 2006;6:68–74
  73. Kew JN, Kemp JA. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl). 2005;179:4–29
  74. Sato K, Kiyama H, Park HT, et al. AMPA: KA and NMDA receptors are expressed in the rat DRG neurones. Neuroreport. 1993;4:1263–1265
  75. Willcockson H, Valtschanoff J. AMPA and NMDA glutamate receptors are found in both peptidergic and non-peptidergic primary afferent neurons in the rat. Cell Tissue Res. 2008;334(1):17–23
  76. Wang H, Zhang RX, Wang R, et al. Decreased expression of N-methyl-D-aspartate (NMDA) receptors in rat dorsal root ganglion following complete Freund's adjuvant-induced inflammation: An immunocytochemical study for NMDA NR1 subunit. Neurosci Lett. 1999;265:195–198
  77. Lu CR, Hwang SJ, Phend KD, et al. Primary afferent terminals that express presynaptic NR1 in rats are mainly from myelinated, mechanosensitive fibers. J Comp Neurol. 2003;460:191–202
  78. Bardoni R, Torsney C, Tong CK, et al. Receptors modulate glutamate release from primary sensory neurons in rat spinal cord dorsal horn. J Neurosci. 2004;24:2774–2781
  79. Liu H, Mantyh PW, Basbaum AI. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature. 1997;386:721–724
  80. Marvizon JC, Martinez V, Grady EF, et al. Neurokinin one receptor internalization in spinal cord slices induced by dorsal root stimulation is mediated by NMDA receptors. J Neurosci. 1997;17:8129–8136
  81. Chen W, Zhang G, Marvizon JC. NMDA receptors in primary afferents require phosphorylation by Src family kinases to induce substance P release in the rat spinal cord. Neuroscience. 2010;(in press)
  82. Li J, McRoberts JA, Ennes HS, et al. Experimental colitis modulates the functional properties of NMDA receptors in dorsal root ganglia neurons. Am J Physiol Gastrointest Liver Physiol. 2006;291:G219–G228
  83. Gaunitz C, Schuttler A, Gillen C, et al. Formalin-induced changes of NMDA receptor subunit expression in the spinal cord of the rat. Amino Acids. 2002;23:177–182
  84. Karlsson U, Sjodin J, Angeby Moller K, et al. Glutamate-induced currents reveal three functionally distinct NMDA receptor populations in rat dorsal horn—Effects of peripheral nerve lesion and inflammation. Neuroscience. 2002;112:861–868
  85. Suckow SK, Caudle RM. NMDA receptor subunit expression and PAR2 receptor activation in colospinal afferent neurons (CANs) during inflammation induced visceral hypersensitivity. Mol Pain. 2009;5:54
  86. Suckow SK, Caudle RM. Identification and immunohistochemical characterization of colospinal afferent neurons in the rat. Neuroscience. 2008;153:803–813
  87. Zhou Q, Caudle RM, Price DD, et al. Selective up-regulation of NMDA-NR1 receptor expression in myenteric plexus after TNBS induced colitis in rats. Mol Pain. 2006;2:3
  88. Hollmann M, Boulter J, Maron C, et al. Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor. Neuron. 1993;10:943–954
  89. Zheng X, Zhang L, Durand GM, et al. Mutagenesis rescues spermine and Zn2+ potentiation of recombinant NMDA receptors. Neuron. 1994;12:811–818
  90. Zhou Q, Caudle RM, Moshiree B, et al. Phosphorylation of NMDA NR1 subunits in the myenteric plexus during TNBS induced colitis. Neurosci Lett. 2006;406:250–255
  91. Scott DB, Blanpied TA, Swanson GT, et al. Receptor ER retention signal regulated by phosphorylation and alternative splicing. J Neurosci. 2001;21:3063–3072
  92. Goelet P, Castellucci VF, Schacher S, et al. The long and the short of long-term memory—A molecular framework. Nature. 1986;322:419–422
  93. Nguyen PV, Abel T, Kandel ER. Requirement of a critical period of transcription for induction of a late phase of LTP. Science. 1994;265:1104–1107
  94. Schuman EM. Synapse specificity and long-term information storage. Neuron. 1997;18:339–342
  95. Bading H, Ginty DD, Greenberg ME. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science. 1993;260:181–186
  96. Pinato G, Pegoraro S, Iacono G, et al. Calcium control of gene regulation in rat hippocampal neuronal cultures. J Cell Physiol. 2009;220:727–747
  97. Jankowski MP, McIlwrath SL, Jing X, et al. Sox11 transcription factor modulates peripheral nerve regeneration in adult mice. Brain Res. 2009;1256:43–54
  98. Naono R, Nakayama T, Ikeda T, et al. Effect of the carboxyl-terminal of endokinins on SP-induced pain-related behavior. Biochem Biophys Res Commun. 2009;378:182–185
  99. Dirig DM, Yaksh TL. Thermal hyperalgesia in rat evoked by intrathecal substance P at multiple stimulus intensities reflects an increase in the gain of nociceptive processing. Neurosci Lett. 1996;220:93–96
  100. Frenk H, Bossut D, Urca G, et al. Is substance P a primary afferent neurotransmitter for nociceptive input? (I. Analysis of pain-related behaviors resulting from intrathecal administration of substance P and 6 excitatory compounds). Brain Res. 1988;455:223–231
  101. Naono R, Nakayama T, Ikeda T, et al. Leucine at the carboxyl-terminal of endokinins C and D contributes to elicitation of the antagonistic effect on substance P in rat pain processing. Brain Res. 2007;1165:71–80
  102. Yoshioka D, Takebuchi F, Nishimori T, et al. Intrathecal administration of the common carboxyl-terminal decapeptide in endokinin A and endokinin B evokes scratching behavior and thermal hyperalgesia in the rat. Neurosci Lett. 2006;410:193–197
  103. Endo D, Ikeda T, Ishida Y, et al. Effect of intrathecal administration of hemokinin-one on the withdrawal response to noxious thermal stimulation of the rat hind paw. Neurosci Lett. 2006;392:114–117
  104. Cao YQ, Mantyh PW, Carlson EJ, et al. Primary afferent tachykinins are required to experience moderate to intense pain. Nature. 1998;392:390–394
  105. De Felipe C, Herrero JF, O'Brien JA, et al. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature. 1998;392:394–397
  106. Fukuoka T, Kondo E, Dai Y, et al. Brain-derived neurotrophic factor increases in the uninjured dorsal root ganglion neurons in selective spinal nerve ligation model. J Neurosci. 2001;21:4891–4900
  107. Jeanjean AP, Moussaoui SM, Maloteaux JM, et al. Interleukin-1beta induces long-term increase of axonally transported opiate receptors and substance P. Neuroscience. 1995;68:151–157
  108. Watkins LR, Maier SF. Beyond neurons: Evidence that immune and glial cells contribute to pathological pain states. Physiol Rev. 2002;82:981–1011
  109. Li P, Zhuo M. Substance P and neurokinin A mediate sensory synaptic transmission in young rat dorsal horn neurons. Brain Res Bull. 2001;55:521–531
  110. Abdulla FA, Stebbing MJ, Smith PA. Effects of substance P on excitability and ionic currents of normal and axotomized rat dorsal root ganglion neurons. Eur J Neurosci. 2001;13:545–552
  111. Wu ZZ, Guan BC, Li ZW, et al. Sustained potentiation by substance P of NMDA-activated current in rat primary sensory neurons. Brain Res. 2004;1010:117–126
  112. Shadiack AM, Sun Y, Zigmond RE. Nerve growth factor antiserum induces axotomy-like changes in neuropeptide expression in intact sympathetic and sensory neurons. J Neurosci. 2001;21:363–371
  113. Watkins LR, Milligan ED, Maier SF. Glial activation: A driving force for pathological pain. Trends Neurosci. 2001;24:450–455
  114. Scholz J, Woolf CJ. The neuropathic pain triad: Neurons, immune cells and glia. Nat Neurosci. 2007;10:1361–1368
  115. Milligan ED, Sloane EM, Watkins LR. Glia in pathological pain: A role for fractalkine. J Neuroimmunol. 2008;198:113–120
  116. Romero-Sandoval EA, Horvath RJ, Deleo JA. Neuroimmune interactions and pain: Focus on glial-modulating targets. Curr Opin Investig Drugs. 2008;9:726–734
  117. Milligan ED, Watkins LR. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci. 2009;10:23–36
  118. McMahon SB, Malcangio M. Current challenges in glia-pain biology. Neuron. 2009;64:46–54
  119. Takeda M, Takahashi M, Matsumoto S. Contribution of the activation of satellite glia in sensory ganglia to pathological pain. Neurosci Biobehav Rev. 2009;33:784–792
  120. Wei F, Guo W, Zou S, Watkins LR, Maier SF. Supraspinal glial-neuronal interactions contribute to descending pain facilitation. J Neurosci. 2008;28:10482–10495
  121. Osikowicz M, Skup M, Mika J, et al. Glial inhibitors influence the mRNA and protein levels of mGlu2/ (3, Five and 7 receptors and potentiate the analgesic effects of their ligands in a mouse model of neuropathic pain). Pain. 2009;147:175–186
  122. Shimizu K, Guo W, Wang H, et al. Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: The effects of interleukin-10 and glial inhibitors. Mol Pain. 2009;5:75
  123. Wordliczek J, Szczepanik AM, Banach M, et al. The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients. Life Sci. 2000;66:1155–1164
  124. Dobrogowski J, Wrzosek A, Wordliczek J. Radiofrequency denervation with or without addition of pentoxifylline or methylprednisolone for chronic lumbar zygapophysial joint pain. Pharmacol Rep. 2005;57:475–480
  125. Dani JW, Chernjavsky A, Smith SJ. Neuronal activity triggers calcium waves in hippocampal astrocyte networks. Neuron. 1992;8:429–440
  126. Pasti L, Zonta M, Pozzan T, et al. Cytosolic calcium oscillations in astrocytes may regulate exocytotic release of glutamate. J Neurosci. 2001;21:477–484
  127. Porter JT, McCarthy KD. Hippocampal astrocytes in situ respond to glutamate released from synaptic terminals. J Neurosci. 1996;16:5073–5081
  128. Parpura V, Haydon PG. Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. Proc Natl Acad Sci USA. 2000;97:8629–8634
  129. Schipke CG, Boucsein C, Ohlemeyer C, et al. Astrocyte Ca2+ waves trigger responses in microglial cells in brain slices. FASEB J. 2002;16:255–257
  130. Gao YJ, Ji RR. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther. 2010;126(1):56–68
  131. Wetmore C, Olson L. Neuronal and nonneuronal expression of neurotrophins and their receptors in sensory and sympathetic ganglia suggest new intercellular trophic interactions. J Comp Neurol. 1995;353:143–159
  132. Gao YJ, Zhang L, Samad OA, et al. JNK-induced MCP-one production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci. 2009;29:4096–4108
  133. Pannese E. The satellite cells of the sensory ganglia. Adv Anat Embryol Cell Biol. 1981;65:1–111
  134. Pannese E, Ledda M, Cherkas PS, et al. Satellite cell reactions to axon injury of sensory ganglion neurons: Increase in number of gap junctions and formation of bridges connecting previously separate perineuronal sheaths. Anat Embryol (Berl). 2003;206:337–347
  135. Hanani M. Satellite glial cells in sensory ganglia: From form to function. Brain Res Brain Res Rev. 2005;48:457–476
  136. Woodham P, Anderson PN, Nadim W, et al. Satellite cells surrounding axotomised rat dorsal root ganglion cells increase expression of a GFAP-like protein. Neurosci Lett. 1989;98:8–12
  137. Stephenson JL, Byers MR. GFAP immunoreactivity in trigeminal ganglion satellite cells after tooth injury in rats. Exp Neurol. 1995;131:11–22
  138. Hanani M, Huang TY, Cherkas PS, et al. Glial cell plasticity in sensory ganglia induced by nerve damage. Neuroscience. 2002;114:279–283
  139. Abbadie C, Lindia JA, Cumiskey AM, et al. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA. 2003;100:7947–7952
  140. Tanaka T, Minami M, Nakagawa T, et al. Enhanced production of monocyte chemoattractant protein 1 in the dorsal root ganglia in a rat model of neuropathic pain: Possible involvement in the development of neuropathic pain. Neurosci Res. 2004;48:463–469
  141. White FA, Sun J, Waters SM, et al. Excitatory monocyte chemoattractant protein 1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci USA. 2005;102:14092–14097
  142. Vit JP, Jasmin L, Bhargava A, et al. Satellite glial cells in the trigeminal ganglion as a determinant of orofacial neuropathic pain. Neuron Glia Biol. 2006;2:247–257
  143. Cherkas PS, Huang TY, Pannicke T, et al. The effects of axotomy on neurons and satellite glial cells in mouse trigeminal ganglion. Pain. 2004;110:290–298
  144. Dublin P, Hanani M. Satellite glial cells in sensory ganglia: Their possible contribution to inflammatory pain. Brain Behav Immun. 2007;21:592–598
  145. Conti F, deBiasi S, Minelli A, et al. Expression of NR1 and NR2A/B subunits of the NMDA receptor in cortical astrocytes. Glia. 1996;17:254–258
  146. Conti F, Barbaresi P, Melone M, et al. Neuronal and glial localization of NR1 and NR2A/B subunits of the NMDA receptor in the human cerebral cortex. Cereb Cortex. 1999;9:110–120
  147. Schipke CG, Ohlemeyer C, Matyash M, et al. Astrocytes of the mouse neocortex express functional N-methyl-D-aspartate receptors. FASEB J. 2001;15:1270–1272
  148. Luque JM, Richards JG. Expression of NMDA 2B receptor subunit mRNA in Bergmann glia. Glia. 1995;13:228–232
  149. Standaert DG, Friberg IK, Landwehrmeyer GB, et al. Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat. Brain Res Mol Brain Res. 1999;64:11–23
  150. Krebs C, Fernandes HB, Sheldon C, et al. Functional NMDA receptor subtype 2B is expressed in astrocytes after ischemia in vivo and anoxia in vitro. J Neurosci. 2003;23:3364–3372
  151. Gottlieb M, Matute C. Expression of ionotropic glutamate receptor subunits in glial cells of the hippocampal CA1 area following transient forebrain ischemia. J Cereb Blood Flow Metab. 1997;17:290–300
  152. Ziak D, Chvatal A, Sykova E. Glutamate-, kainate- and NMDA-evoked membrane currents in identified glial cells in rat spinal cord slice. Physiol Res. 1998;47:365–375

PII: S1084-208X(10)00024-8

doi: 10.1053/j.trap.2010.04.001

Techniques in Regional Anesthesia & Pain Management
Volume 14, Issue 2 , Pages 48-58 , April 2010

Article Tools